PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+16.7%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.44B
AUM Growth
+$2.44B
(+29%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
11.54%
Top 10 Holdings %
Top 10 Hldgs %
36.96%
Holding
98
New
23
Increased
18
Reduced
15
Closed
20
Top Buys
| 1 |
Universal Health Services
UHS
|
$60.8M |
| 2 |
Eli Lilly
LLY
|
$59.2M |
| 3 |
McKesson
MCK
|
$53.7M |
| 4 |
AbbVie
ABBV
|
$45.5M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$44.8M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$114M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$33.8M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$29.5M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$23.8M |
| 5 |
Microsoft
MSFT
|
$20M |
Sector Composition
| 1 | Healthcare | 92.27% |
| 2 | Financials | 0.44% |
| 3 | Consumer Discretionary | 0% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$37.5B
| $31.9M | 1.12% |
77,740
| – | – |
|
|
AERI
27
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $30.1M | 1.06% |
2,227,611
| – | – |
|
28
Guardant Health
GH
$8.11B
| $29.4M | 1.03% |
+227,876
| New | +$29.4M |
|
|
MYOV
29
DELISTED
Myovant Sciences Ltd.
MYOV
| $28.9M | 1.02% |
1,046,212
+417,940
| +67% | +$11.5M |
|
30
Biogen
BIIB
$20.8B
| $28.1M | 0.99% |
114,604
+24,888
| +28% | +$6.09M |
|
31
Bristol-Myers Squibb
BMY
$96.7B
| $28M | 0.98% |
+451,275
| New | +$28M |
|
|
32
BioMarin Pharmaceuticals
BMRN
$11.3B
| $27.6M | 0.97% |
314,499
-385,553
| -55% | -$33.8M |
|
33
Henry Schein
HSIC
$8.14B
| $26.4M | 0.93% |
395,161
-7,149
| -2% | -$478K |
|
34
Labcorp
LH
$22.8B
| $26.1M | 0.92% |
128,100
-15,223
| -11% | -$3.1M |
|
|
PPD
35
DELISTED
PPD, Inc. Common Stock
PPD
| $25.4M | 0.89% |
742,863
-45,000
| -6% | -$1.54M |
|
36
Pfizer
PFE
$141B
| $25.2M | 0.89% |
685,125
+206,764
| +43% | +$6.66M |
|
37
Novavax
NVAX
$1.2B
| $24.1M | 0.85% |
+215,908
| New | +$24.1M |
|
|
TCRR
38
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $24M | 0.84% |
775,794
| – | – |
|
39
Icon
ICLR
$14B
| $23.7M | 0.83% |
121,323
| – | – |
|
40
Waters Corp
WAT
$17.3B
| $23.4M | 0.82% |
+94,497
| New | +$23.4M |
|
|
CANO
41
DELISTED
Cano Health, Inc.
CANO
| $22.4M | 0.79% |
+1,669,565
| New | +$22.4M |
|
42
Molina Healthcare
MOH
$9.6B
| $21.7M | 0.76% |
101,907
-60,617
| -37% | -$12.9M |
|
43
Pulmonx
LUNG
$67.6M
| $20.3M | 0.71% |
+302,631
| New | +$20.3M |
|
44
Cytokinetics
CYTK
$5.98B
| $20.2M | 0.71% |
+971,151
| New | +$20.2M |
|
45
Centene
CNC
$14.8B
| $19.7M | 0.69% |
+328,479
| New | +$19.7M |
|
46
Shattuck Labs
STTK
$61.3M
| $16.2M | 0.57% |
+386,813
| New | +$16.2M |
|
47
Athira Pharma
ATHA
$15.5M
| $16.1M | 0.57% |
470,227
+77,738
| +20% | +$2.66M |
|
48
Ionis Pharmaceuticals
IONS
$9.64B
| $14.9M | 0.52% |
+263,412
| New | +$14.9M |
|
|
ADAP
49
Adaptimmune Therapeutics
ADAP
$13.9M
| $14.5M | 0.51% |
2,694,769
+1,845,329
| +217% | +$9.95M |
|
50
Zai Lab
ZLAB
$3.48B
| $14.5M | 0.51% |
+107,061
| New | +$14.5M |
|